Aon GLP-1 Study: Reduced Rise in Medical Costs for Users, Pronounced Benefits for Women
In May 2025, Aon released the first phase of a US study of GLP-1 medications for diabetes and weight management. Across the global technology sector, employers are facing unprecedented complexity—distributed teams, dynamic regulations, and rapidly evolving expectations around pay, benefits, and wellbeing. Aon’s role is to help tech companies cut through this complexity, using data […]
Aon GLP-1 Study: Reduced Rise in Medical Costs for Users, Pronounced Benefits for Women Read More »